Menopause is an Economic Issue: The Retention Argument Your Board Hasn't Heard Yet

The business case for menopause support in the workplace does not rest on compassion. It rests on workforce economics. The employees most likely to be affected by menopause symptoms — women aged 45 to 55 — represent a disproportionate share of organisational seniority, institutional knowledge, and leadership capability in most UK businesses. When those employees leave, reduce their hours, or disengage from their roles because their employer has not provided adequate support, the financial consequences are real and measurable. This piece sets out the retention argument in terms that Finance Directors and boards can evaluate — and the benefits design response that addresses the risk.

Why Menopause is a Workforce Planning Issue, Not a Wellbeing One

The categorisation matters. A wellbeing issue sits in the HR function, attracts a limited budget, and is measured in employee satisfaction scores. A workforce planning issue sits in the Finance function, attracts a cost-benefit analysis, and is measured in headcount stability, recruitment cost, and productivity impact. Menopause-related attrition is the latter.

The CIPD's menopause and the people profession guidance identifies menopause as one of the most significant and under-addressed causes of talent loss among experienced female employees. The CIPD has documented the proportion of women who have considered leaving their job or reducing their hours because of menopause symptoms — a figure that, when applied to the seniority profile of most organisations, represents a substantial proportion of the senior female talent pipeline.

This is not a niche issue affecting a small number of employees. According to ONS Labour Force Survey data, women aged 45 to 54 represent one of the largest and most economically active cohorts in the UK workforce. The overlap between this group and the workforce population affected by perimenopause and menopause is direct and significant. Employers who are not addressing this are carrying a retention risk that is not reflected in their workforce planning models.

The Attrition Profile: Who's Leaving and What it Costs to Replace Them

The employees most likely to exit or reduce engagement because of unaddressed menopause symptoms are not junior staff. They are experienced managers, senior professionals, and leaders with a decade or more of institutional knowledge. The replacement cost for these employees is significantly higher than for entry or mid-level roles.

The CIPD has published estimates of replacement cost across roles and seniority levels. For a senior professional or manager — typically defined as a role requiring specialist knowledge or team leadership responsibility — the combined cost of recruitment, onboarding, reduced productivity during the ramp-up period, and lost institutional knowledge typically represents a multiple of annual salary. ACAS's guidance on menopause at work places the cost of replacing an experienced employee in senior roles at a figure that, applied to an employer losing two or three such employees per year to menopause-related attrition, produces a board-level financial exposure.

The calculation for Finance Directors is straightforward: identify the number of women aged 45 to 55 in the organisation, estimate the proportion who may be experiencing significant symptoms (the CIPD data provides a reasonable basis for this), apply the replacement cost for their seniority band, and compare that figure to the cost of implementing a meaningful menopause support programme. In almost all cases, the cost of the programme is a fraction of the attrition risk it mitigates.

The Productivity Impact: Absence, Presenteeism, and the Performance Gap

Attrition is the most visible cost, but it is not the only one. The CIPD's menopause guidance documents the extent to which menopause symptoms affect productivity for employees who remain in post but receive no support. The symptoms — which can include cognitive difficulties, fatigue, disrupted sleep, anxiety, and physical discomfort — are not conducive to high performance in demanding roles. Presenteeism among this group (attending work while symptomatic and unable to perform effectively) is a documented phenomenon with a measurable productivity cost.

Absence is also affected. Menopause symptoms that are not managed — either medically or through workplace support — lead to increased sickness absence. For Finance Directors tracking absence cost as a percentage of payroll, the contribution of unaddressed menopause symptoms is difficult to isolate but not difficult to estimate once the workforce demographics are examined.

The performance gap — the difference between what an experienced senior employee delivers when appropriately supported and what they deliver when managing significant symptoms without support — represents a real but unmeasured cost. It does not appear in the accounts. It appears in missed deadlines, team performance, client relationship quality, and strategic output. These are the costs that are hardest to quantify and easiest to underestimate.

What Employers Are Currently Doing — and Why Most of it isn't Working

The most common employer response to menopause in 2025 is a policy document and a link to an Employee Assistance Programme. For the majority of affected employees, this is insufficient. A policy document signals intent; it does not provide support. An EAP link puts the burden of navigation on the employee at a point when she may have the least capacity to navigate it.

The Fawcett Society's menopause and the workplace research has consistently found that awareness among line managers — the people in the best position to provide immediate support — is low across most UK organisations. A menopause policy that exists at the organisational level but has not been communicated to, or understood by, the line managers responsible for implementing it is a policy that does not function.

The employers whose menopause provision is working share three characteristics: their line managers have been trained and are confident having conversations about menopause; their HR and benefits provision includes flexible working arrangements that can be accessed without a protracted process; and their culture communicates that using this provision is both acceptable and expected, rather than a sign of vulnerability or special treatment.

The Commercial Case: What Retaining One Additional Senior Leader is Worth

The commercial case for menopause support does not require complex modelling. It requires two inputs: the replacement cost for a senior employee in the relevant role, and the cost of the menopause support programme being considered.

As an illustrative framework: a senior manager or experienced professional in a UK business might be on a total remuneration package of £70,000 to £100,000. The replacement cost — including recruitment agency fees (typically 15–20% of salary), onboarding time, management bandwidth consumed during the hiring process, and the productivity gap during the six to twelve months it takes a new hire to reach full effectiveness — is commonly estimated at 50% to 100% of annual salary. That is £35,000 to £100,000 per departure.

If a meaningful menopause support programme — covering manager training, flexible working facilitation, enhanced EAP access, and benefits adjustments — costs £10,000 to £20,000 per year to operate, and that programme retains two senior employees who would otherwise have left, the return on investment is immediate and substantial. The risk is not spending the money. The risk is not spending the money and absorbing the attrition cost instead.

What a Serious Menopause Support Framework Looks Like in Practice

The ACAS menopause at work guidance provides a clear framework for employers building or reviewing their provision. The components that carry the most practical weight are:

1. A written menopause policy. This should do more than state that the employer takes menopause seriously. It should set out what support is available, how to access it, what adjustments can be requested, and what the process is. Signposting a policy without specifying what it contains is not a policy — it is an aspiration.

2. Manager training. Line managers are the primary point of contact for employees needing support. If they are not trained and confident in how to respond, the policy fails at the first point of implementation. Training does not need to be extensive — an hour of structured guidance significantly improves a manager's ability to have an effective conversation.

3. Flexible working access. Many menopause symptoms are manageable if the employee has control over their working environment, schedule, or location. A flexible working policy that is genuinely accessible — not one that requires a formal application process with a lengthy decision timeline — is one of the most effective interventions available.

4. Benefits that address the specific needs of this group. Enhanced EAP access with specific menopause pathways, private health cover that includes menopause consultations, and wellbeing benefits that support the management of symptoms are all relevant. The benefits should be communicated specifically — not buried in a generic benefits guide — so that affected employees know they exist.

5. A culture that normalises using the provision. The most carefully designed policy will underperform if the workplace culture makes using it feel like an admission of incapacity. Senior leadership visibility — including male leaders explicitly supporting menopause provision — is the most effective signal that the policy is genuine.

The Benefits Design Question: Which Elements of a Benefits Package Actually Help

The benefits most directly relevant to menopause support are not always framed as menopause-specific. Flexible working benefits, health cash plans, enhanced private medical cover, and EAP counselling provision all serve this population — but only if they are communicated in a way that makes their relevance to menopause explicit.

An employee navigating perimenopause symptoms who does not know her employer offers private GP consultations, or who has not been told that her EAP includes menopause-specific mental health support, is not receiving the benefit — even though the employer is paying for it. This is the Benefit Literacy Gap in its most direct form: the employer has funded the provision, but the employee cannot use it because she does not know it exists or how to access it.

The decision support function — helping employees navigate to the right benefit at the right point in their working life — is exactly where Perky's Benefit Intelligence Platform operates. Benefits that are discoverable and explained in context of the employee's situation produce meaningfully higher utilisation than benefits listed in a static catalogue.

How Finance Should Model This — From Attrition Cost to Programme Cost

The modelling framework for Finance Directors is a four-step calculation:

1. Identify the at-risk population. Use payroll data to establish the number of female employees aged 45 to 55. This is the population for whom menopause-related attrition is a plausible risk.

2. Apply a realistic attrition estimate. The CIPD menopause guidance provides data on the proportion of affected women who have considered leaving their job. Apply this figure conservatively to establish the expected number of departures per year in the absence of support.

3. Calculate the replacement cost per departure. Use the organisation's actual recruitment cost data — or a conservative estimate of 50% of annual salary if specific data is not available — multiplied by the number of expected departures.

4. Compare to programme cost. Set the expected attrition cost against the cost of implementing and running a meaningful menopause support programme for one year. If the attrition cost exceeds the programme cost — which it will in any organisation with more than a small number of women in the relevant age bracket — the investment case is made without reference to wellbeing arguments, cultural values, or policy benchmarking.